Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 2 (2005), Issue 1 (January)

1. Homozygosity for the 168His variant of the minor histocompatibility antigen HA-1 is associated with reduced risk of primary Sjögren's syndrome.
   Eur J Immunol, 35(1): 305-17. [Abstract] [Full-text]
2. Proinflammatory mediators elicit secretion of the intracellular B-lymphocyte stimulator pool (BLyS) that is stored in activated neutrophils: implications for inflammatory diseases.
   Blood, 105(2): 830-7. [Abstract] [Full-text]
3. Modified Sauvé-Kapandji procedure for disorders of the distal radioulnar joint in patients with rheumatoid arthritis.
   J Bone Joint Surg Am, 87(1): 134-9. [Abstract] [Full-text]
4. Rheumatoid arthritis: neuroendocrine immune integrated physiopathogenetic perspectives and therapy.
   Rheum Dis Clin North Am, 31(1): 131-60, x. [Abstract] [Full-text]
5. Circadian rhythms and arthritis.
   Rheum Dis Clin North Am, 31(1): 115-29, ix-x. [Abstract] [Full-text]
6. Controlling pain by influencing neurogenic pathways.
   Rheum Dis Clin North Am, 31(1): 103-13, ix. [Abstract] [Full-text]
7. Sympathetic neurotransmitters in joint inflammation.
   Rheum Dis Clin North Am, 31(1): 43-59, viii. [Abstract] [Full-text]
8. Estrogens and arthritis.
   Rheum Dis Clin North Am, 31(1): 19-27, vii. [Abstract] [Full-text]
9. Quantification of bone lesions in rheumatoid arthritis by MRI multispectral tissue class transition analysis.
   Semin Musculoskelet Radiol, 8(4): 301-11. [Abstract] [Full-text]
10. Magnetic resonance imaging of the synovium in rheumatoid arthritis.
    Semin Musculoskelet Radiol, 8(4): 287-99. [Abstract] [Full-text]
11. Imaging of bone erosion in rheumatoid arthritis.
    Semin Musculoskelet Radiol, 8(4): 269-85. [Abstract] [Full-text]
12. Salivary gland and temporomandibular joint involvement in rheumatoid arthritis: relation to disease activity.
    Oral Dis, 11(1): 27-34. [Abstract] [Full-text]
13. Immunohistochemistry of the B-cell component in lower lip salivary glands of Sjögren's syndrome and healthy subjects.
    Scand J Immunol, 61(1): 98-107. [Abstract] [Full-text]
14. Mud compress therapy for the hands of patients with rheumatoid arthritis.
    Rheumatol Int, 25(1): 49-54. [Abstract] [Full-text]
15. An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritis.
    Rheumatol Int, 25(1): 15-22. [Abstract] [Full-text]
16. Protein kinase C expression in salivary gland acinar epithelial cells in non-obese diabetic mice, an experimental model for Sjögren's syndrome.
    Rheumatol Int, 25(1): 28-32. [Abstract] [Full-text]
17. Cost-effectiveness analysis of NSAIDs, NSAIDs with concomitant therapy to prevent gastrointestinal toxicity, and COX-2 specific inhibitors in the treatment of rheumatoid arthritis.
    Rheumatol Int, 25(1): 9-14. [Abstract] [Full-text]
18. Activation markers of peripheral blood mononuclear cells in late pregnancy and after delivery: a pilot study.
    Ann Rheum Dis, 64(2): 318-20. [Abstract] [Full-text]
19. Relative responsiveness of condition specific and generic health status measures in juvenile idiopathic arthritis.
    Ann Rheum Dis, 64(2): 257-61. [Abstract] [Full-text]
20. No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitis.
    Ann Rheum Dis, 64(2): 235-8. [Abstract] [Full-text]
21. Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison.
    Ann Rheum Dis, 64(2): 212-6. [Abstract] [Full-text]
22. Low levels of dehydroepiandrosterone sulphate in plasma, and reduced sympathoadrenal response to hypoglycaemia in premenopausal women with rheumatoid arthritis.
    Ann Rheum Dis, 64(2): 202-6. [Abstract] [Full-text]
23. Seven year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis.
    Ann Rheum Dis, 64(2): 191-5. [Abstract] [Full-text]
24. p53 expression in rheumatoid and psoriatic arthritis synovial tissue and association with joint damage.
    Ann Rheum Dis, 64(2): 183-7. [Abstract] [Full-text]
25. The development of the EULAR-OMERACT rheumatoid arthritis MRI reference image atlas.
    Ann Rheum Dis, 64: i8-10. [Abstract] [Full-text]
26. Pitfalls in scoring MR images of rheumatoid arthritis wrist and metacarpophalangeal joints.
    Ann Rheum Dis, 64: i48-55. [Abstract] [Full-text]
27. An introduction to the EULAR-OMERACT rheumatoid arthritis MRI reference image atlas.
    Ann Rheum Dis, 64: i3-7. [Abstract] [Full-text]
28. The EULAR-OMERACT rheumatoid arthritis MRI reference image atlas: the metacarpophalangeal joints.
    Ann Rheum Dis, 64: i11-21. [Abstract] [Full-text]
29. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Arthritis Rheum, 52(1): 27-35. [Abstract] [Full-text]
30. Association of SLC11A1 (NRAMP1) with persistent oligoarticular and polyarticular rheumatoid factor-negative juvenile idiopathic arthritis in Finnish patients: haplotype analysis in Finnish families.
    Arthritis Rheum, 52(1): 247-56. [Abstract] [Full-text]
31. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report.
    Arthritis Rheum, 52(1): 61-72. [Abstract] [Full-text]
32. Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis.
    Arthritis Rheum, 52(1): 239-46. [Abstract] [Full-text]
33. Increased CD4+ T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis.
    Arthritis Rheum, 52(1): 73-9. [Abstract] [Full-text]
34. Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus.
    Arthritis Rheum, 52(1): 219-24. [Abstract] [Full-text]
35. Presentation and analysis of data on radiographic outcome in clinical trials: experience from the TEMPO study.
    Arthritis Rheum, 52(1): 49-60. [Abstract] [Full-text]
36. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.
    Arthritis Rheum, 52(1): 36-41. [Abstract] [Full-text]
37. C-reactive protein as a predictor of infliximab treatment outcome in patients with rheumatoid arthritis: defining subtypes of nonresponse and subsequent response to etanercept.
    Arthritis Rheum, 52(1): 42-8. [Abstract] [Full-text]
38. Responses of lymphocytes of patients with rheumatoid arthritis to IgG modified by oxygen radicals or peroxynitrite.
    Arthritis Rheum, 52(1): 80-3. [Abstract] [Full-text]
39. A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease.
    Arthritis Rheum, 52(1): 269-74. [Abstract] [Full-text]
40. Heterogeneity testing in meta-analysis of genome searches.
    Genet Epidemiol, 28(2): 123-37. [Abstract] [Full-text]
41. Prognostic laboratory markers of joint damage in rheumatoid arthritis.
    Ann Rheum Dis, 64(2): 196-201. [Abstract] [Full-text]
42. Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis.
    Ann Rheum Dis, 64(2): 229-34. [Abstract] [Full-text]
43. First clinical evaluation of sagittal laser optical tomography for detection of synovitis in arthritic finger joints.
    Ann Rheum Dis, 64(2): 239-45. [Abstract] [Full-text]
44. Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change.
    Ann Rheum Dis, 64(2): 179-82. [Abstract] [Full-text]
45. Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis.
    Ann Rheum Dis, 64(2): 303-5. [Abstract] [Full-text]
46. Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept.
    Ann Rheum Dis, 64(2): 246-52. [Abstract] [Full-text]
47. Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalities.
    Ann Rheum Dis, 64(2): 207-11. [Abstract] [Full-text]
48. Open label trial of anakinra in active ankylosing spondylitis over 24 weeks.
    Ann Rheum Dis, 64(2): 296-8. [Abstract] [Full-text]
49. Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases.
    Ann Rheum Dis, 64(2): 262-6. [Abstract] [Full-text]
50. Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.
    Ann Rheum Dis, 64(2): 299-302. [Abstract] [Full-text]
51. Hepatitis C virus, Sjögren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer.
    Autoimmun Rev, 4(1): 8-15. [Abstract] [Full-text]
52. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
    Soc Sci Med, 60(7): 1571-82. [Abstract] [Full-text]
53. Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis.
    Circulation, 111(2): 204-11. [Abstract] [Full-text]
54. The value of the qualitative method for adaptation of a disease-specific quality of life assessment instrument: the case of the Rheumatoid Arthritis Quality of Life Scale (RAQoL) in Estonia.
    Health Qual Life Outcomes, 2(1): 69. [Abstract] [Full-text]
55. The polymorphisms of Tim-1 promoter region are associated with rheumatoid arthritis in a Korean population.
    Immunogenetics, 56(10): 696-701. [Abstract] [Full-text]
56. Patient initiated outpatient follow up in rheumatoid arthritis: six year randomised controlled trial.
    BMJ, 330(7484): 171. [Abstract] [Full-text]
57. Results of total hip arthroplasty with bone graft and support ring for protrusio acetabuli in rheumatoid arthritis.
    J Orthop Sci, 10(1): 8-14. [Abstract] [Full-text]
58. LIGHT is involved in the pathogenesis of rheumatoid arthritis by inducing the expression of pro-inflammatory cytokines and MMP-9 in macrophages.
    Immunology, 114(2): 272-9. [Abstract] [Full-text]
59. Albuminuria and tubular markers in juvenile idiopathic arthritis.
    Pediatr Nephrol, 20(2): 154-8. [Abstract] [Full-text]
60. Various secretory phospholipase A2 enzymes are expressed in rheumatoid arthritis and augment prostaglandin production in cultured synovial cells.
    FEBS J, 272(3): 655-72. [Abstract] [Full-text]
61. Incidence of vertebral deformities in 255 female rheumatoid arthritis patients measured by morphometric X-ray absorptiometry.
    Osteoporos Int, 16(1): 35-42. [Abstract] [Full-text]
62. Rofecoxib for rheumatoid arthritis.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
63. A visual analogue scale for assessment of the impact of rheumatoid arthritis in the hand: validity and repeatability.
    J Hand Ther, 18(1): 30-3. [Abstract] [Full-text]
64. Comparison of early and late pleuropulmonary findings of ankylosing spondylitis by high-resolution computed tomography and effects on patients' daily life.
    Clin Rheumatol, 24(1): 22-8. [Abstract] [Full-text]
65. Debilitating diarrhoea and weight loss due to colitis in two RA patients treated with leflunomide.
    Clin Rheumatol, 24(1): 87-90. [Abstract] [Full-text]
66. Adaptation of the Bath Ankylosing Spondylitis Functional Index to the Turkish population, its reliability and validity: functional assessment in AS.
    Clin Rheumatol, 24(1): 41-7. [Abstract] [Full-text]
67. Relationship between high-resolution computed tomography findings and the Stoke index in patients with rheumatoid arthritis.
    Clin Rheumatol, 24(1): 14-7. [Abstract] [Full-text]
68. Constraints on the efficacy of mucosal tolerance in treatment of human and animal arthritic diseases.
    Ann N Y Acad Sci, 1029: 250-9. [Abstract] [Full-text]
69. DRESS syndrome in a patient on sulfasalazine for rheumatoid arthritis.
    Joint Bone Spine, 72(1): 82-5. [Abstract] [Full-text]
70. Correlations between high-resolution computed tomography of the chest and clinical function in patients with rheumatoid arthritis. Prospective study in 75 patients.
    Joint Bone Spine, 72(1): 41-7. [Abstract] [Full-text]
71. Role for innate immunity in rheumatoid arthritis.
    Joint Bone Spine, 72(1): 17-25. [Abstract] [Full-text]
72. The role of leukocyte-stromal interactions in chronic inflammatory joint disease.
    Joint Bone Spine, 72(1): 10-6. [Abstract] [Full-text]
73. Cardiovascular disease and psychological morbidity among rheumatoid arthritis patients.
    Rheumatology (Oxford), 44(2): 241-6. [Abstract] [Full-text]
74. Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-alpha inhibitors.
    Rheumatology (Oxford), 44(2): 172-5. [Abstract] [Full-text]
75. Clinical and pathological differences between Mikulicz's disease and Sjögren's syndrome.
    Rheumatology (Oxford), 44(2): 227-34. [Abstract] [Full-text]
76. Prevalence of Sjögren's syndrome in ambulatory patients according to the American-European Consensus Group criteria.
    Rheumatology (Oxford), 44(2): 235-40. [Abstract] [Full-text]
77. Isolated inflammatory coxitis associated with protrusio acetabuli: a new form of juvenile idiopathic arthritis?
    Rheumatology (Oxford), 44(2): 219-26. [Abstract] [Full-text]
78. Topoisomerase II inhibitors, irrespective of their chemical composition, ameliorate experimental arthritis.
    Rheumatology (Oxford), 44(2): 183-6. [Abstract] [Full-text]
79. Debridement of plantar callosities in rheumatoid arthritis: a randomized controlled trial.
    Rheumatology (Oxford), 44(2): 207-10. [Abstract] [Full-text]
80. Working status among Dutch patients with rheumatoid arthritis: work disability and working conditions.
    Rheumatology (Oxford), 44(2): 202-6. [Abstract] [Full-text]

© 2004-2008 Rheumatoid Arthritis Research Today. All Rights Reserved.